Not available
Quote | Pacira BioSciences Inc. (NASDAQ:PCRX)
Last: | $30.61 |
---|---|
Change Percent: | 0.39% |
Open: | $30.7 |
Close: | $30.61 |
High: | $30.9045 |
Low: | $30.235 |
Volume: | 680,308 |
Last Trade Date Time: | 05/20/2024 03:00:00 am |
News | Pacira BioSciences Inc. (NASDAQ:PCRX)
2024-05-10 07:17:48 ET More on Pacira BioSciences Pacira Biosciences announces proposed offering of $250M aggregate principal amount of convertible senior notes Pacira BioSciences up 12% on stock buyback, Q1 top-line beat Read the full article on Seeking Alpha ...
TAMPA, Fla., May 10, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX) today announced the pricing of $250.0 million aggregate principal amount of convertible senior notes due 2029 (the “notes”) in a private placement to qualified institutional buyers pursuant to Rule...
Message Board Posts | Pacira BioSciences Inc. (NASDAQ:PCRX)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $PCRX News Article - Pacira BioSciences Partners with The Invited Celebrity Classic - a | whytestocks | investorshangout | 04/20/2023 7:10:47 PM |
whytestocks: $PCRX News Article - Pacira BioSciences, Inc. Appoints Christopher Young as Chief Manuf | whytestocks | investorshangout | 04/19/2023 4:35:50 PM |
whytestocks: $PCRX News Article - Pacira BioSciences Announces Positive Topline Data from Phase 3 St | whytestocks | investorshangout | 09/21/2022 6:40:48 PM |
wow, can you imagine if we will hit | stockstobuy | investorshub | 05/25/2022 3:05:06 AM |
Wow this company only issued a small note | stockstobuy | investorshub | 05/25/2022 2:36:18 AM |
News, Short Squeeze, Breakout and More Instantly...
Pacira BioSciences Inc. Company Name:
PCRX Stock Symbol:
NASDAQ Market:
Pacira BioSciences Inc. Website:
TAMPA, Fla., May 10, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX) today announced the pricing of $250.0 million aggregate principal amount of convertible senior notes due 2029 (the “notes”) in a private placement to qualified institutional buyers pursuant to Rule...
TAMPA, Fla., May 08, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX) today announced that it intends to offer, subject to market and other conditions, $250.0 million aggregate principal amount of convertible senior notes due 2029 (the “notes”) in a private placement...
-- Conference call today at 4:30 p.m. ET -- TAMPA, Fla., May 07, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today reported financial results for the first quarter of...